PLSE
Closed
Pulse Biosciences Inc
14.84
-0.25 (-1.66%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 15.09
Day's Range: 14.69 - 15.3278
Send
sign up or login to leave a comment!
When Written:
3.81
Pulse Biosciences Inc. is a medical technology company that develops and commercializes a proprietary platform technology called Nano-Pulse Stimulation (NPS). NPS is a non-thermal, precise and controlled technology that uses nanosecond electrical pulses to disrupt cellular structures and trigger cell death. This technology has potential applications in a variety of medical fields, including dermatology, oncology, and aesthetics.
The company's flagship product, the CellFX System, is designed for use in dermatology and is intended to treat a variety of skin conditions, including sebaceous hyperplasia, seborrheic keratosis, and cutaneous squamous cell carcinoma. The CellFX System received FDA clearance in 2020 and is currently being commercialized in the United States.
Pulse Biosciences was founded in 2014 and is headquartered in Hayward, California. The company is publicly traded on the NASDAQ under the ticker symbol PLSE.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
The company's flagship product, the CellFX System, is designed for use in dermatology and is intended to treat a variety of skin conditions, including sebaceous hyperplasia, seborrheic keratosis, and cutaneous squamous cell carcinoma. The CellFX System received FDA clearance in 2020 and is currently being commercialized in the United States.
Pulse Biosciences was founded in 2014 and is headquartered in Hayward, California. The company is publicly traded on the NASDAQ under the ticker symbol PLSE.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








